Ongoing Clinical Trials

Indication
Institution
Department
Principal Investigator
Protocol Title
TMU-JIRB No. Protocol Title Indication Institution Department Principal Investigator Contact
N202102065 Phase III Study of Trastuzumab Deruxtecan (T-DXd) with or without Pertuzumab versus Taxane, Trastuzumab and Pertuzumab in HER2-positive, First-line Metastatic Breast Cancer (DESTINY-Breast09) Breast Cancer SHH Hematology and Oncology Tsu-Yi Chao Jheng-Yi Liou
0979448117
N202307004 A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2−) (HER2 IHC0 or HER2-low [IHC 1+, IHC 2+/ISH−]) Inoperable, Locally Advanced, or Metastatic Breast Cancer and Have Received Endocrine Therapy Breast Cancer SHH Hematology and Oncology Tsu-Yi Chao Jheng-Yi Liou
0979448117
N202012049 An Exploratory, Randomised, Double-blind, Parallel-Group, Placebo-Controlled Phase IIa Study to Assess the Analgesic Activity of PAX-1 in Patients with Persistent Cancer Pain. Persistent Cancer Pain SHH Hematology and Oncology Tsu-Yi Chao Jheng-Yi Liou
0979448117
N202012037 SERENA-4: A Randomised, Multicentre, Double-Blind, Phase III Study of AZD9833 (an Oral SERD) plus Palbociclib versus Anastrozole plus Palbociclib for the Treatment of Patients with Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease Breast Cancer SHH Hematology and Oncology Wei-Hong Cheng Jheng-Yi Liou
0979448117
N202104068 A Phase I, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Clinical Activity of OB318 in Patients with Advanced Solid Malignancies Solid tumors SHH Hematology and Oncology Wei-Hong Cheng Cih Cuei
0915521015
N202210086 A Phase I, Open-label, Dose-escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Modified Salmonella Typhimurium SGN1 Administered via Intratumoral Injection in Patients with Advanced Solid Tumors Solid tumors SHH Hematology and Oncology Wei-Hong Cheng Yi-Ping Ji
0958790027
N202404021 A Phase 1/2a, Multicenter, Open-Label, First in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of DB-1311 in Subjects with Advanced/Metastatic Solid Tumors Solid tumors SHH Hematology and Oncology Wei-Hong Cheng Siao-Yu Liou
0937518688
N202401013 A Randomized, Double-Blind Study Evaluating the Efficacy, Safety, and Immunogenicity of ABP 206 Compared with OPDIVO® (Nivolumab) in Subjects with Treatment-Naïve Unresectable or Metastatic Melanoma Melanoma SHH Hematology and Oncology Yao-Yu Hsieh Jheng-Yi Liou
0979448117
1 2 3 4 5 6 7 8 9 10 11 12 13 / 13

TOP